A dramatic auction failure dominated the health and bio small-cap space, with BSF Enterprise losing nearly half its market value after its high-profile T-Rex leather handbag failed to sell. Elsewhere, patent and regulatory milestones drove modest gains at Cizzle Biotechnology and GSK.